Lyu X, Li Z, Chen S, et al. Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia. Clin Neurophysiol. 2024;166:20-30. doi:10 ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In 2024, several research and pharmacological ...

A 28-year-old Middle Eastern man develops severe motor disturbances, including muscle rigidity, tremors, a parkinsonian gait, and involuntary, jerky limb movements, following the administration of a 3 ...

Differentiating tardive dyskinesia from other movement disorders can be challenging. "One major criterion is the history of ...

A new study published in the Asian Journal of Psychiatry showed that people of Indian heritage require lower effective ...

US neuroscience-focused biopharma Neurocrine Biosciences presented new data from more than 300 patients diagnosed with tardive dyskinesia and treated with Ingrezza (valbenazine) capsules at the 2024 ...

Teva has filed its SD-809 in the US for tardive dyskinesia, a rare disorder characterised by uncontrollable movements of the face and body, for which there is no approved treatment. The filing ...

Credit: Getty Images This patient fact sheet describes the medications that are known to induce tardive dyskinesia, its symptoms, and ways in which the disease state may be managed. Our easy-to ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new patient- and physician-reported ...

(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) Monday said data from Phase 3 KINECT-3 and KINECT-4 studies showed that treatment with Ingrezza brought holistic improvements over time in patients with ...

IMPACT-TD Registry, the largest study evaluating holistic effects of tardive dyskinesia (TD), highlights that there is a high burden of TD on quality of life regardless of a person’s underlying mental ...

The IMPACT-TD Registry is the largest study of its kind evaluating the holistic effects of tardive dyskinesia (TD), showing real-world treatment patterns and outcomes with once-daily AUSTEDO XR ...